News
- Allakos, Inc is conducting trial of Lirentelimab (AK002) for active eosinophilic duodenitis
- Bausch Health Americas, Inc is evaluating Amiselimod (MT-1303) in Ulcerative Colitis
- SCReN is testing COMIRNATY vaccine in subjects received VAXZEVRIA
- Erasca, Inc is recruiting patients for the clinical trial of ERAS-007 in Patients With Advanced or Metastatic Solid Tumors (HERKULES-1) (HERKULES-1).
- Servicio de Salud Metropolitano Sur Oriente is recruiting patients with locally advanced rectal cancer
- Erasca, Inc is commencing the clinical trial of ERAS-007 for solid tumors
- Mamta Parikh is testing Selinexor and Pembrolizumab in patients with cisplatin-ineligible urothelial carcinoma
- The company Alladapt Immunotherapeutics, Inc is commencing a study of the ADP101 in food-allergic children and adults
- The company ModernaTX, Inc is commencing the clinical of mRNA-1273 Vaccine in Adult Organ Transplant Recipients
- Elicio Therapeutics started a new clinical trial of ELI-002 immunotherapy for KRAS Mutated Pancreatic Ductal Adenocarcinoma
- Independent Public Clinical Hospital No. 4 in Lublin is recruiting patients for the clinical trial of Amantadine in the prevention of progression and treatment of COVID-19 Symptoms
- ProQR Therapeutics is recruiting patients for the clinical trial of Sepofarsen in Children (<8 Years of Age) with LCA10
- The research company ACADIA Pharmaceuticals Inc is conducting the clinical trial of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy.
- MonTa Biosciences ApS is recruiting patients for the clinical trial of of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours.
- Relmada Therapeutics, Inc is recruiting patients for the clinical trial to assess the efficacy and safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II).
- Vir Biotechnology, Inc. will begin a study of VIR-2218 + VIR-3434 in Subjects With Chronic Hepatitis B Virus Infection (MARCH)
- The company Walvax Biotechnology Co., Ltd is commencing recruitment for the clinical study to evaluate the protective Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate
- The research company Tilman S.A is conducting the clinical trial to evaluate the efficacy and safety of NASAFYTOL® on COVID-19 positive hospitalized patients.
- Erasmus Medical Center is starting a new clinical trial of Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis.
- Aarhus University Hospital is about to start an ALLTogether study of Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase.
- Veru Inc starts an Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer.
- Weill Medical College of Cornell University is about to start a Phase 2, Open-Label, Single-Arm Study of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma.
- BioFactura Australia Pty Ltd started a new bioequivalence Phase I Study of BFI-751 Compared With EU-STELARA® and US-STELARA® in Healthy Adult Volunteers.
- A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors.
- The company ImmunityBio, Inc is commencing recruitment for the clinical trial of the COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines.
Clinical Research News
다가오는 임상 시험
-
Aperta Biosciences, LLC아직 모집하지 않음
-
Hospices Civils de Lyon아직 모집하지 않음요실금 | 신경성 방광 | 요로 전환 | 골반 악성종양 | 방광암프랑스
-
Second Affiliated Hospital, Zhejiang University...모병정상적인 청력 | 소음 노출 | Preferred Loudness Level중국
-
Qilu Pharmaceutical Co., Ltd.아직 모집하지 않음투명 세포 신장 세포 암종 | 난소 암 | 기타 진행성 고형 종양중국
-
University Hospital, Antwerp아직 모집하지 않음신생아의 괴사성 소장결장염 | 후기 발병 신생아 패혈증벨기에, 네덜란드
-
VA Office of Research and Development아직 모집하지 않음전이성 비소세포폐암 | Cancer-Associated Weight Loss | Elevated Inflammatory Markers미국
-
ENTire Medical Ltd.아직 모집하지 않음비대 | 편도선 절제술 | 기도 폐쇄 갑피 | 아데노이드절제술미국
-
AbbVie아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital...모병
-
Ahmed Nasser Ali Mabkhout모병턱 낭종 | Alveolar Bone Defects예멘
-
University of Coimbra아직 모집하지 않음
